What is Medifast's EV / EBITDA?

Medifast (MED) reported EV / EBITDA of 1,292.6× in Q4 2025.

How has Medifast's EV / EBITDA changed year-over-year?

Medifast's EV / EBITDA increased by 16984.5% year-over-year, from 7.6× to 1,292.6×.

What is the long-term trend for Medifast's EV / EBITDA?

Over 4 years (2021 to 2025), Medifast's EV / EBITDA has grown at a 232.4% compound annual growth rate (CAGR), from 10.6× to 1,292.6×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Medifast MED EV / EBITDA

EV / EBITDA at other companies

Eli LillyLLY

25.9×-24.4×

WW International, Inc.WW

31.3×-7.0×

HerbalifeHLF

5.3×0.0×

Lifevantage CorporationLFVN

5.6×-5.1×

The Beachbody CompanyBODI

3.2×—

Other financials

Income statement

See full

Revenue$76.0M-34.3%

Gross profit$51.8M-38.6%

Operating income-$3.3M-161%

Net income-$2.1M-175%

EPS (diluted)-$0.19-171%

Balance sheet

See full

Cash & equivalents$71.5M-22.0%

Total debt$16.1M+10.2%

Total equity$197.7M-6.3%

Total assets$252.0M-10.0%

Cash flow

See full

Operating cash flow$260.0K-92.4%

CapEx$1.1M-28.0%

Free cash flow-$836.0K-144%

Valuation

See full

Market cap$121.87M-17.4%

Enterprise value$66.44M+12.8%

P/S0.4×0.0×

Profitability

See full

Gross margin70.1%-3.8pp

Operating margin-4.7%-7.0pp

Net margin-5.8%-8.1pp

FCF margin5%-9.3pp

Returns & leverage

See full

Return on equity-9.8%-20.1pp

Debt / equity0.1×0.0×

Current ratio4.8×+1.3×

Where this comes from

Calculated from Medifast’s reported figures.

enterprise value/ebitda=1,292.6×

Based on the most recent quarter.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medifast's EV / EBITDA?: Medifast (MED) reported EV / EBITDA of 1,292.6× in Q4 2025.
How has Medifast's EV / EBITDA changed year-over-year?: Medifast's EV / EBITDA increased by 16984.5% year-over-year, from 7.6× to 1,292.6×.
What is the long-term trend for Medifast's EV / EBITDA?: Over 4 years (2021 to 2025), Medifast's EV / EBITDA has grown at a 232.4% compound annual growth rate (CAGR), from 10.6× to 1,292.6×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.